Smith, L.A., Morris, A.J. and Stanley, A.J. (2014) The use of hemospray in portal hypertensive bleeding; a case series. Journal of Hepatology, 60(2), pp. 457-460. (doi: 10.1016/j.jhep.2013.10.008) (PMID:24140803)
Full text not currently available from Enlighten.
Abstract
Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastrointestinal bleeding (NVUGIB) in Europe and Canada. Hemospray has been shown to be safe and effective in achieving haemostasis in bleeding peptic ulcers in a prospective clinical study and several further case series have described the use of hemospray in other non-variceal causes of gastrointestinal bleeding. Portal hypertensive gastropathy and colopathy are common in patients with portal hypertension. As hemospray is an easy to apply, non-contact method, which can cover large areas of mucosa, it may be of benefit in acute non-variceal portal hypertensive bleeding. We present data from the first four consecutive patients presenting to our institution with acute haemorrhage secondary to non-variceal diffuse portal hypertensive bleeding treated with hemospray.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Stanley, Dr Adrian |
| Authors: | Smith, L.A., Morris, A.J., and Stanley, A.J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | Journal of Hepatology |
| Publisher: | Elsevier |
| ISSN: | 0168-8278 |
| Published Online: | 17 October 2013 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details